September 28, 2026 04:32 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Asif bhai gun nikal': 17-year-old's chilling account of men posing as cops raping her in South Delhi park | Indian passport rules changed: New validity, fees for children and adults explained | 'Terrorism by Pakistan will have consequences': India issues blunt warning at UNGA | Trouble for Gyanesh Kumar? Plea filed in Supreme Court seeking prosecution of CEC | Air India pilot suspended after failing alcohol test before Zurich-Delhi flight, weeks after marijuana case | 'Don't be selective, boycott all elections': CJP's Abhijeet Dipke's blunt message to Opposition | 'Resign by tomorrow or face nationwide protest from October 2': CJP's Abhijeet Dipke's fresh warning to Gyanesh Kumar | 'Locked' iPhone 17 at centre of mystery surrounding IIT Bombay student's death | 'Rahul Gandhi is devoid of wisdom and knowledge': BJP hits back over 'vote theft' claim | ‘How does anti-incumbency disappear?’: Rahul Gandhi targets Modi, Shah in fresh ‘vote chori’ attack, demands Gyanesh Kumar’s resignation
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.